secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-04-21T23:59:59+00:00
Accession:  0001193125-26-165205
Event type: regulatory
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics regains Nasdaq minimum bid price compliance after 1-for-25 reverse split
--------------------------------------------------------------------------------

- Nasdaq notified Plus Therapeutics on April 20, 2026 that bid price closed at or above $1.00 for 10 consecutive days through April 17.
- Reverse stock split (1-for-25) was effective April 2, 2026 and enabled compliance with Listing Rule 5550(a)(2).
- Nasdaq has closed the matter; PSTV common stock remains listed on The Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526165205/0001193125-26-165205-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526165205/pstv-20260420.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-165205

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer